Total Payments
$8,568
2024 Payments
$17.74
Companies
37
Transactions
550
Medicare Patients
410
Medicare Billing
$43,608
Payment Breakdown by Category
Food & Beverage$8,514 (99.4%)
Education$35.55 (0.4%)
Other$17.74 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,514 | 543 | 99.4% |
| Education | $35.55 | 6 | 0.4% |
| Debt forgiveness | $17.74 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,311 | 109 | $0 (2022) |
| Novo Nordisk Inc | $1,008 | 111 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,007 | 55 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $678.27 | 37 | $0 (2021) |
| Lilly USA, LLC | $526.18 | 39 | $0 (2021) |
| PFIZER INC. | $514.78 | 39 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $480.80 | 35 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $471.57 | 32 | $0 (2021) |
| GlaxoSmithKline, LLC. | $292.03 | 16 | $0 (2022) |
| Amgen Inc. | $150.09 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.74 | 1 | Baxter Healthcare ($17.74) |
| 2022 | $165.68 | 9 | GlaxoSmithKline, LLC. ($34.96) |
| 2021 | $1,295 | 66 | AstraZeneca Pharmaceuticals LP ($268.34) |
| 2020 | $1,018 | 52 | AstraZeneca Pharmaceuticals LP ($393.59) |
| 2019 | $1,782 | 107 | AstraZeneca Pharmaceuticals LP ($483.92) |
| 2018 | $1,933 | 135 | AstraZeneca Pharmaceuticals LP ($518.50) |
| 2017 | $2,357 | 180 | AstraZeneca Pharmaceuticals LP ($631.95) |
All Payment Transactions
550 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/03/2024 | Baxter Healthcare | — | Debt forgiveness | In-kind items and services | $17.74 | General |
| 03/29/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, PEDIARIX | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: VACCINES | ||||||
| 03/15/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/10/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, PEDIARIX | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: VACCINES | ||||||
| 03/08/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Diabetes Care | ||||||
| 02/22/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: CNS | ||||||
| 02/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Diabetes | ||||||
| 02/01/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/14/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/21/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: DIABETES | ||||||
| 12/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/02/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX, PEDIARIX | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: VACCINES | ||||||
| 11/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/26/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/19/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $11.59 | General |
| Category: Cardiovascular | ||||||
| 10/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 31 | 35 | $5,810 | $1,702 |
| 2021 | 3 | 146 | 253 | $37,420 | $20,673 |
| 2020 | 5 | 233 | 369 | $45,864 | $21,234 |
Total Patients
410
Total Services
657
Medicare Billing
$43,608
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 35 | $5,810 | $1,702 | 29.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 74 | 156 | $25,790 | $13,832 | 53.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 81 | $8,935 | $4,694 | 52.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 16 | 16 | $2,695 | $2,147 | 79.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 93 | 181 | $20,091 | $8,859 | 44.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 121 | $20,086 | $8,317 | 41.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 21 | 21 | $3,765 | $2,447 | 65.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 23 | 23 | $1,715 | $1,403 | 81.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 23 | 23 | $207.00 | $207.00 | 100.0% |
About Dr. Robert Fallstrom, D.O
Dr. Robert Fallstrom, D.O is a Family Medicine healthcare provider based in Yakima, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922033604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Fallstrom, D.O has received a total of $8,568 in payments from pharmaceutical and medical device companies, with $17.74 received in 2024. These payments were reported across 550 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($8,514).
As a Medicare-enrolled provider, Fallstrom has provided services to 410 Medicare beneficiaries, totaling 657 services with total Medicare billing of $43,608. Data is available for 3 years (2020–2022), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Yakima, WA
- Active Since 07/11/2006
- Last Updated 06/11/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922033604
Products in Payments
- FARXIGA (Drug) $1,667
- JARDIANCE (Drug) $553.94
- Victoza (Drug) $451.75
- XARELTO (Drug) $419.52
- Ozempic (Drug) $419.10
- INVOKANA (Drug) $258.75
- SYMBICORT (Drug) $257.96
- SOLIQUA (Drug) $245.94
- JANUVIA (Drug) $233.36
- EMGALITY (Drug) $180.21
- CHANTIX (Drug) $160.80
- STIOLTO (Drug) $155.38
- SPIRIVA RESPIMAT (Drug) $143.45
- Amitiza (Drug) $126.26
- TRULICITY (Drug) $124.49
- PRADAXA (Drug) $117.57
- TRADJENTA (Drug) $116.28
- ELIQUIS (Drug) $108.16
- SHINGRIX (Biological) $100.14
- BEVESPI AEROSPHERE (Drug) $100.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Yakima
Theodore Vye, Do, DO
Family Medicine — Payments: $22,423
Family Medicine $22,423
Portia Jones, Md, Mph, MD, MPH
Family Medicine — Payments: $19,452
Family Medicine $19,452
Vani Bremjit, Md, MD
Family Medicine — Payments: $16,355
Family Medicine $16,355
Dr. John Lyzanchuk, Do, DO
Family Medicine — Payments: $13,174
Family Medicine $13,174
Joseph Dimeo, D.o, D.O
Family Medicine — Payments: $11,508
Family Medicine $11,508
Scott Heflick, Md, MD
Family Medicine — Payments: $7,382
Family Medicine $7,382